Instructions to Authors

1. GENERAL CONSIDERATION
Prepare your Manuscripts for Online submission as indicated below. These standards are necessary for peer-reviewing.

  • Submitted papers should be in the English Language.
  • The manuscript should be submitted as an MS Word Document.
  • The manuscript should be prepared as per journal guidelines.
  • All papers are subjected to scientific peer review.
  • All papers must be submitted online after registering as an author.

 

2. STANDARDS FOR SUBMISSION

I. Covering Letter

Should contain

  • Name, Address, Email id, Mobile No. of the Author for Correspondence.
  • The letter should mention in brief what is already known about this subject and what new has added by the submitted work.
  • Title of the paper.
  • Authors' initials and names
  • An abstract (not exceeding 10 lines) which should be most informative, giving clear indications of the nature and range of the results contained in the paper, and should not duplicate the conclusions.
  • 3 to 4 keywords
II. Length

There is no restriction on the length of the manuscript. However, a concise manuscript with all information is always well appreciated.

III. Abbreviations

Abbreviations to be defined where they first appear in the text.

IV. Nomenclature

Please follow the correct and accepted Nomenclature
Units of measurement
Indicate SI units directly or in Parentheses after the value.
Drugs
Provide the Recommended International Non-Proprietary Name (rINN).
Species names
Mention species names in Italics. The Genus and Species name should be mentioned in Full, in title as well as wherever the organism name is first mentioned. After the first mention, the first letter of the Genus name followed by the Full species name is used.
For Genetic Nomenclatures, please refer to the recommended name by consulting the Genetic Nomenclature database.
Genes, mutations, genotypes, and alleles Write in italics. Use the recommended name by consulting the appropriate genetic nomenclature database (e.g., HUGO for human genes). It is sometimes advisable to indicate the synonyms for the gene the first time it appears in the text. Gene prefixes such as those used for oncogenes or cellular localization should be shown in the roman typeface (e.g., v-fes, c-MYC).

 

3. PREPARATION OF MANUSCRIPT

The Manuscripts should follow the IMRad format (Introduction- Method- Results and Discussion). For more information, please read (https://en.wikipedia.org/wiki/IMRAD).
All original research articles should be structured in the following manner.

3.1. Title

The title should be concise and reflect the entire work of the submitted manuscript.

3.2. Affiliation

Below the title, all author names should be mentioned along with Affiliation of each author. 1. Affiliation details should include-

  • Department
  • University
  • Organization
  • City with Pincode
  • State
  • Country for all authors

2. Each author’s affiliation should be identified by a superscript small numeral.
3. Author for correspondence should be indicated by an asterisk.
4. Provide full address including e-mail, fax, and telephone number of Author for correspondence.

3.3. Abstract

Abstracts need not be in a structured format. However, it should clearly state

  • The purpose of the work
  • Methods used
  • Key findings and the major conclusion is drawn from the work in no more than 500 words
  • Use of abbreviations in abstract should be avoided however if essential should be expanded at its first appearance
3.4. Keywords

The author should provide 3 to 6 keywords, characterizing the scope of the paper, Keywords should be written in title case and separated by a comma. Avoid general and plural terms and multiple concepts (avoid, for example, 'and', 'of').

3.5. Headings

Authors to number the headings in Arabic Style Eg: 1, 2….

  • Headings should be in title case, meaning that all words except for prepositions, articles, and conjunctions should be capitalized.
  • All botanical names should be in italics.
    • For example: 1. Finite Element Modelling (FEM)
                        1.1 Model Description

Botanical Name: Ulam Herbs of Oenanthejavanica and Cosmoscaudatus: an overview on their Medicinal Properties

3.6. Introduction

State the background and mention clearly the objective of the present work.

3.7. Materials and Methods

All methods used should be clearly mentioned. This will allow other researchers to reproduce your work. Wherever required, give correct formula used for calculation

3.8. Results

Results obtained in the study should be subjected to appropriate statistical methods and presented clearly. The findings should never be discussed in this section.

3.9. Discussion

It should have a rationale and be of relevance to the present study along with the existing literature. Discuss the lacuna in the area and to how much extent the present study has answered the research question and provide directions for further research. Please avoid repeating the Results of your studies under this section.

3.10. Conclusion

Give the major conclusion from the present study. This section may stand alone or be clubbed together with discussion.

3.11. Acknowledgments

Acknowledge those persons who helped you in the present study by providing facilities, personal assistance and funding if any.

3.12. Footnotes

Footnotes are not permitted. If the manuscript contains footnotes, move them into the text and references as per the content.

3.13. References

JHSR follows the Vancouver style of referencing.

a. In the Referencing
  • References within the text of the article should be represented by numbers and should be superscripted.
  • The number originally assigned to a reference should be re-used if that reference is cited again later in the text.
  • In case of multiple references, separate the numbers with a hyphen. E.g. 2-5, or commas in case of non-inclusive numbers E.g. 3, 9, 14.
  • As a general rule, reference numbers should be placed outside of full-stops and commas, and inside of colons and semicolons.

Eg. Hoppert M. Microscopic techniques in biotechnology. Weinheim: Wiley-VCH; 2003. Gillespie NC, Lewis RJ, Pearn JH, Bourke ATC, Holmes MJ, Bourke JB, et al. Ciguatera in Australia: occurrence, clinical features, pathophysiology, and management. Med J Aust. 1986;145:584-90.

b. Reference List
  • References that are cited in the text should be mentioned here.
  • It should appear at the end of your text.
  • It should be arranged numerically by citation number.
c. Referencing journal articles
  • Elements of the Citation: Author(s) – Family name and initials. Title of article. Title of journal – abbreviated. Publication year, month, day (month & day only if available);volume(issue):pages E.g. 10. Halpern HD, Yadav GA, Caplan KL. Treatment of human brucellosis: systematic review and meta-analysis of randomized controlled trials. BMJ. 2005 Mar 24;336(7646):701-4.
d. Referencing Books
  • Elements of the Citation: Author(s) – Family name and initials, Multiple authors separated by a comma. Title of book. Place of Publication: Publisher Name; Year of Publication.
    E.g. McKenna DJ, Jones K, Hughes K. Social care practice in rural communities. New York: Oxford University Press; 2000.
e. For edited books
  • Elements of the Citation: Author(s) – Family name and initials, Multiple authors separated by a comma. In name of book editors followed by a comma and editors. Title of book. Edition of book if later than 1st ed. Place of Publication: Publisher Name; Year of Publication.
    E.g. Rowlands TE, Haine LS. Acute limb ischemia. In: Donnelly R, London NJM, editors. ABC of arterial and venous disease. 2nd ed. West Sussex. Blackwell Publishing; 2009.
f. Tables
  • Tables should be numbered consecutively in accordance with their appearance in the text.
  • They should be embedded in appropriate locations as per the text along with the captions.
  • Place Legends for tables below the table body and indicate them with lowercase letters in superscript.
  • Avoid vertical rules and ensure that the data presented in tables do not duplicate results described elsewhere in the article.
  • Please note that tables embedded as Excel files within the manuscript are NOT accepted.
  • Tables in Excel should be copied and pasted into the manuscript Word file.
g. Figures
  • These must be numbered and cited in the text.
  • Mark clearly in the margin of the manuscript where the figure is to be inserted and do not embed in the text.
  • Tables should be numbered consecutively in accordance with their appearance in the text.
  • All figures should be in TIFF.
  • Images provided should be with the below-mentioned resolutions:
                   Black & White Images - 900 dpi
                   ColouredImages - 600 dpi
                   Line art-grey colour - 600 dpi
  • Photo resolution should be a minimum 300 dpi.
  • Histograms should be presented in a simple, two-dimensional format,with no background grid.
  • Supply figure captions separately and not attached to the figure.
  • The legends should be provided along with the figures.

 

4. ETHICAL APPROVALS

Patient Rights

Patients have a right to privacy thus; all the studies should be conducted with informed consent. No identifying information should be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. When informed consent has been obtained, it should be indicated in the article. Investigations with human subjects must follow the ethical standards formulated in the Helsinki Declaration of 1964, revised in 2013. All the experiments should be approved by the institutional human experimentation committee or equivalent.  

Animal Rights

Animal experiments must follow the ethical standards for the care and use of laboratory animals. The article involved the animal experiments must seek approval(s) from the appropriate Ethical Committee in accordance with the "Guide for the Care and Use of Laboratory Animals" and ARRIVE guidelines. 

4.1. Studies based on clinical trials:

Clinical trials must follow the CONSORT guidelines. We advise the authors to register the clinical trials with a clinical trial registry that allows free online access to the public. Registration in the following trial registers is acceptable:

http://www.ctri.in
http://www.clinicaltrials.gov/
http://www.actr.org.au/
http://isrctn.org/
http://www.umin.ac.jp/ctr
http://www.trialregister.nl/trialreg/index.asp

Reporting Guidelines for Specific Study Designs

Type of Study

Registration Initiative

Source

Randomized controlled trials

CONSORT

http://www.consort-statement.org

Studies of diagnostic accuracy

STARD

http://www.consort-statement.org/stardstatement.htm

Systematic reviews and meta-analyses

QUOROM

http://www.consort-statement.org/Initiatives/MOOSE/moose.pdf 

Observational studies in epidemiology

STROBE

http://www.strobe-statement.org

Meta-analyses of observational studies in epidemiology 

MOOSE

http://www.consort-statement.org/Initiatives/MOOSE/moose.pdf

 

5. AUTHORSHIP AND ACKNOWLEDGEMENTS

5.1. Authorship

All the authors in a manuscript are equally responsible for the technical information communicated to the journal. Thus, it is necessary that all authors must read and approve the final version of the manuscript before submitting it to the journal. All named authors must have made an active contribution to the conception and design and/or analysis and interpretation of the data and/or the drafting of the paper and all must have critically reviewed its content and have approved the final version submitted for publication. Participation solely in the acquisition of funding or the collection of data does not justify authorship.

JHSR follows the definition of authorship given by the International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria:

  • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  • Drafting the work or revising it critically for important intellectual content; AND
  • Final approval of the version to be published; AND
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Authors should meet all four conditions.  All the manuscripts should contain the Authors’ Contributions statement immediately before the Acknowledgments section. 

5.2.Acknowledgments

All acknowledgments should be included at the very end of the paper before the references and may include supporting grants, presentations, and so forth. Contributors who do not qualify as authors should be mentioned under Acknowledgements.

 

6. CONFLICT OF INTEREST  

All the authors must disclose the possible conflicts of interest/Competing Interests they may have with the publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript. The Conflict of Interest statement should list each author separately by name. The ICMJE has developed a Disclosure Form to facilitate and standardize authors’ disclosures, please click this link to download the ICMJE COI form. Authors are required to upload the duly filled and signed form under the additional files section, during manuscript submission. They can also send it by email to editor@jhsronline.com. Please follow the link to read the detailed ICMJE recommendations for disclosure of financial and non-financial relationships and activities, and conflicts of interest. 

 

7. FUNDING SOURCES 

The authors must declare all sources of funding received for the research submitted to the journal. Authors should give the name of granting agencies and grant numbers, along with a short description of each funder’s role.  Only the funding related to the submitted work should be mentioned and authors are NOT required to provide the complete list of every single grant that supports them. 

 

8. ORIGINALITY AND PLAGIARISM

Authors should ensure the originality of their contents while preparing a manuscript draft. In case the authors have used the work and/or words of others this must be appropriately cited or quoted. All the articles submitted to JAPS shall be screened for plagiarism using iThenticate (online plagiarism detection software). In case, plagiarism is detected during the review/editorial process, such manuscript(s) will be rejected immediately. Please read our plagiarism policy for details.

 

9. REPORTING STANDARDS

Authors of the original research article must present accurate data of work performed during their research. Authors are also expected to discuss the objective of their work and the significance of their results. An article should contain sufficient information and references to ensure the reproducibility of the work. Fraudulent or knowingly inaccurate statements considered unethical behavior and are unacceptable.

 

10. DATA ACCESS AND RETENTION

Authors may be asked to provide the raw/supplementary data for a paper that is under editorial review. The authors should be prepared to provide the public access to these data (if practicable) and to retain such data for a reasonable time after the publication.

Download Article Template

Overview of Production Process